# China NMPA Product Recall - Drug infusion system

Source: https://www.globalkeysolutions.net/records/china_product_recall/medtronic-inc/f01f3acf-d1a0-43c2-b71a-be0534ae6900
Source feed: China

> China NMPA product recall for Drug infusion system by Medtronic Inc. published May 16, 2014. Recall level: . On May 16, 2014, the National Medical Products Administration (NMPA) published a recall notice regar

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Medtronic, Inc. of the United States has issued a recall for its drug infusion systems.
- Company Name: Medtronic Inc.
- Publication Date: 2014-05-16
- Product Name: Drug infusion system
- Recall Reason: Medtronic has determined that some affected batches of filler bags may contain a blocked extension tube, which may prevent healthcare professionals from aspirating the SynchroMed® pump when using the affected filler bags. Aside from potentially requiring re-infusion, there are no other effects on patients.
- Discovering Company: Medtronic (Shanghai) Management Co., Ltd.
- Manufacturing Company: Medtronic Inc.
- Summary: On May 16, 2014, the National Medical Products Administration (NMPA) published a recall notice regarding drug infusion systems manufactured by Medtronic, Inc., and distributed by Medtronic (Shanghai) Management Co., Ltd. Medtronic voluntarily initiated this recall on May 12, 2014, in response to a critical manufacturing issue affecting specific batches of their SynchroMed® pump filler bags (Registration Certificate No.: CFDA (Imported) No. 20103543342).The core problem identified was the potential presence of a blocked extension tube within these filler bags. This defect could impede healthcare professionals' ability to properly aspirate the pump, thereby posing a risk of re-infusion for patients. Medtronic clarified that, while other patient effects were not noted, the re-infusion risk necessitated the recall.Crucially, Medtronic confirmed that the affected products were neither imported into nor sold within the Chinese market. Nevertheless, the NMPA proactively instructed all provincial, autonomous region, and municipal food and drug administrations to strengthen their oversight and management of similar medical devices. The company's formal corrective action for China was listed as 'Not Applicable,' reflecting the absence of direct product sales in the region, yet highlighting the NMPA's continued regulatory vigilance.

Company: https://www.globalkeysolutions.net/companies/medtronic-inc/398d5f72-c7d2-4c97-94fc-fbef4cf2336d